IDH mutation-related hematological malignancies
Conditions
Interventions
Observation group:None
Sponsors
Southern Medical University Southern Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign the informed consent form; 2. Age: 18 years or older; 3. Diagnosis: Pathologically or hematologically confirmed malignant hematologic tumor (such as leukemia, lymphoma, multiple myeloma, etc.); 4. Treatment stage: Currently undergoing treatment (including chemotherapy, targeted therapy, immunotherapy, hematopoietic stem cell transplantation, etc.) or in the post-treatment follow-up stage; 5. Cognitive ability: Possess sufficient cognitive ability to understand and complete the study questionnaire.
Exclusion criteria
Exclusion criteria: 1. Severe cognitive impairment: Individuals with severe cognitive impairments (such as dementia, mental disorders, etc.) that may affect their understanding of and responses to the questionnaire; 2. Severe mental illness: Individuals with severe mental illnesses (such as schizophrenia, bipolar disorder, etc.) that may affect the reliability of the research results; 3. Inability to communicate: Individuals who are unable to communicate effectively with the research team due to language barriers or other reasons; 4. Other major illnesses: Individuals with other major illnesses (such as severe heart disease, respiratory failure, etc.) that may affect their ability to participate in the study or pose additional risks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 34-item Supportive Care Need Survey; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Questionnaire-Core30;Patient Health Questionnaire-9;Comprehensive Scores for Financial Toxicity based on the Patient-Reported Outcome Measures;Generalized Anxiety Disorder-7;Memorial Symptom Assessment Scale; | — |
Countries
China
Contacts
Public ContactYao Jingjing
Southern Medical University Southern Hospital
Outcome results
None listed